hotspot -WSS

hotspot

author：leisure time 2025-09-28 23:30:41 - browse：1

Eric Lander White House science office — Eric Lander resigned as President Biden’s science adviser, after a White House investigation found “credible evidence” that he had violated workplace conduct rules. Photo illustration: Alex Hogan/STAT; Source: Getty

WASHINGTON — An early sign that trouble was afoot in the White House science office came last November, when roughly a dozen of Eric Lander’s staff formed a “culture committee” aimed at improving morale.

The group’s first action, five aides told STAT, was to create a “word cloud” depicting the adjectives they most often used to describe the work environment at the White House Office of Science and Technology Policy. Of the dozens of words submitted, three in particular stood out: “hostile,” “siloed,” and “aggressive.”

Three months later, Lander resigned as President Biden’s science adviser, after Politico reported a White House investigation that found “credible evidence” that he had violated workplace conduct rules.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Let's speed up science by embracing open access publishing

WSS

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

What affirmative action's end means to a medical student

Intellia reports positive results for its CRISPR

Ionis drug prevents swelling attacks due to hereditary angioedema

ASCO: AstraZeneca's Tagrisso greatly slowed some lung cancers

Crowdfunding for unproven stem cell procedures spreads misinformation

hotspot

hotspot

entertainment

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

ASCO: AstraZeneca says CAR

Trump demands the U.S. pay no more for drugs than other countries … again

Archived: an online chat discussing Ebola, vaccines, and a new epidemic

What does generative AI mean for health care? We asked experts

At ASCO, AstraZeneca reports strong data for breast cancer drug

Drug repurposing or repositioning? The language matters

Hubble vs. James Webb telescope images: See the difference

Psychedelics group wrestles with new pharma identity

Prescription digital therapeutics are key to pharma’s future

explore

At ASCO, AstraZeneca reports strong data for breast cancer drug

Cord blood banking comes at a high cost to babies

The biotech scorecard for Q3: 15 stock

Change Healthcare can notify patients about the breach, HHS says

Skip the lead apron during X

Vertex cell therapy lets patients with type 1 diabetes stop insulin

entertainment

hotspot

entertainment

hotspot